[
  {
    "ts": null,
    "headline": "AbbVie (ABBV) Gains As Market Dips: What You Should Know",
    "summary": "AbbVie (ABBV) concluded the recent trading session at $177.70, signifying a +0.85% move from its prior day's close.",
    "url": "https://finnhub.io/api/news?id=9901c3b24a45b1a0e6f2432984bc4c1db4ab830e043295dc00852e652e4ee59b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735685119,
      "headline": "AbbVie (ABBV) Gains As Market Dips: What You Should Know",
      "id": 132223674,
      "image": "https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (ABBV) concluded the recent trading session at $177.70, signifying a +0.85% move from its prior day's close.",
      "url": "https://finnhub.io/api/news?id=9901c3b24a45b1a0e6f2432984bc4c1db4ab830e043295dc00852e652e4ee59b"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie (ABBV) Upgraded to Buy: What Does It Mean for the Stock?",
    "summary": "AbbVie (ABBV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
    "url": "https://finnhub.io/api/news?id=5f757be6cfb2a859f7883f86aa2eb060d81de1c833f8f76ddf06457c37540d5c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735664412,
      "headline": "AbbVie (ABBV) Upgraded to Buy: What Does It Mean for the Stock?",
      "id": 132223675,
      "image": "https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (ABBV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
      "url": "https://finnhub.io/api/news?id=5f757be6cfb2a859f7883f86aa2eb060d81de1c833f8f76ddf06457c37540d5c"
    }
  },
  {
    "ts": null,
    "headline": "10 stocks retail investors craved in 2024",
    "summary": "It has been another great year for retail investors.",
    "url": "https://finnhub.io/api/news?id=0f572cccfe4a1e19d1fbacad16bfb0e6f3527da02869a42cc1699101d2448591",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735661551,
      "headline": "10 stocks retail investors craved in 2024",
      "id": 132215443,
      "image": "https://s.yimg.com/ny/api/res/1.2/fxgY40h5GrdsS0vcx7yukA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2024-12/981892a0-c790-11ef-b343-04a981da914c",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "It has been another great year for retail investors.",
      "url": "https://finnhub.io/api/news?id=0f572cccfe4a1e19d1fbacad16bfb0e6f3527da02869a42cc1699101d2448591"
    }
  },
  {
    "ts": null,
    "headline": "Are Medical Stocks Lagging  Anavex Life Sciences (AVXL) This Year?",
    "summary": "Here is how Anavex Life Sciences (AVXL) and AbbVie (ABBV) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=10fa3591b562e7daab0d895aa3e54e448199ce8ba6e7a307a78732e5bf33cf23",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735656012,
      "headline": "Are Medical Stocks Lagging  Anavex Life Sciences (AVXL) This Year?",
      "id": 132223678,
      "image": "https://media.zenfs.com/en/zacks.com/5ecaf2a9bf082a5f3a554e6526b34be0",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Here is how Anavex Life Sciences (AVXL) and AbbVie (ABBV) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=10fa3591b562e7daab0d895aa3e54e448199ce8ba6e7a307a78732e5bf33cf23"
    }
  },
  {
    "ts": null,
    "headline": "Brokers Suggest Investing in AbbVie (ABBV): Read This Before Placing a Bet",
    "summary": "The average brokerage recommendation (ABR) for AbbVie (ABBV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
    "url": "https://finnhub.io/api/news?id=d2236297acc60ff597f843a991981b21674ff33f8e0af0488b7445c40909605e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735655413,
      "headline": "Brokers Suggest Investing in AbbVie (ABBV): Read This Before Placing a Bet",
      "id": 132223679,
      "image": "",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The average brokerage recommendation (ABR) for AbbVie (ABBV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
      "url": "https://finnhub.io/api/news?id=d2236297acc60ff597f843a991981b21674ff33f8e0af0488b7445c40909605e"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finnhub.io/api/news?id=1ed0cc13a96436bc98cf3d2027c561ecd47532d57a2f50c5d8f8f5879d0256d9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735653620,
      "headline": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 132223680,
      "image": "https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=1ed0cc13a96436bc98cf3d2027c561ecd47532d57a2f50c5d8f8f5879d0256d9"
    }
  },
  {
    "ts": null,
    "headline": "Is AbbVie Inc. (ABBV) the Best Dividend Stock of 2024?",
    "summary": "We recently compiled a list of the Top 20 Dividend Stocks of 2024. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other dividend stocks. Macroeconomic factors have weighed on US stocks in the final days of the year, with the broader market declining by over 1% […]",
    "url": "https://finnhub.io/api/news?id=463741ac3308081549d85553094ca73ab36d9dca961d6dd031e3a31654560be5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735641414,
      "headline": "Is AbbVie Inc. (ABBV) the Best Dividend Stock of 2024?",
      "id": 132212795,
      "image": "https://s.yimg.com/ny/api/res/1.2/m1YYSOl9HO_x0LHuYGlC8Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the Top 20 Dividend Stocks of 2024. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other dividend stocks. Macroeconomic factors have weighed on US stocks in the final days of the year, with the broader market declining by over 1% […]",
      "url": "https://finnhub.io/api/news?id=463741ac3308081549d85553094ca73ab36d9dca961d6dd031e3a31654560be5"
    }
  }
]